Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001493152-24-038663
Filing Date
2024-09-30
Accepted
2024-09-30 06:07:17
Documents
1
Period of Report
2024-06-30
Effectiveness Date
2024-09-30

Document Format Files

Seq Description Document Type Size
1 formnt10-k.htm NT 10-K 20549
  Complete submission text file 0001493152-24-038663.txt   21845
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Filer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: NT 10-K | Act: 34 | File No.: 000-55320 | Film No.: 241336466
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)